Thank you, Minister, for being here.
I'm going to switch gears and talk about antimicrobial resistance.
As you may recall, this committee did a study on antimicrobial resistance and released a report quite recently.
The prevalence of microbes that are becoming resistant to our pharmaceuticals, our antibiotics, is a major issue. It's an emerging issue around the world. Effective antibiotics are critical to much of modern medicine, such as major surgeries. One of our recommendations was for a national surveillance system. I recently had a delegation in my office from some health care agencies who were asking specifically for that.
I'm wondering if you can speak to any actions that might be under way toward a national surveillance system for antimicrobial resistance.
Also, I'm interested in whether incentives and perhaps research money are available for the development of new vaccines, which is becoming ever more critical as we go forward.
Thank you.